To the Editor:
Mpox, caused by the monkeypox virus (MPXV), has been associated with adverse pregnancy outcomes, but evidence of vertical transmission remains limited.1–3 Concerns of transplacental transmission are heightened by the ongoing Clade Ib mpox epidemic, which often affects individuals of reproductive age.4 We report three cases of Clade Ib MPXV infection in pregnant women, providing molecular and histopathological evidence of transplacental transmission across all trimesters. (Details of methodology, clinical presentation, and histopathology are in the supplementary appendix.)
The first case involved a woman at six weeks of gestation who developed fever, generalized rash, inguinal adenopathy, and genital edema and tested positive for Clade Ib MPXV. Despite symptomatic treatment, she experienced a spontaneous abortion. MPXV DNA was detected in embryonic and placental tissues, with Ct values of 13.4 and 20.1, respectively (Table). Histopathology of these tissues demonstrated MPXV antigen colocalized with CD68 positive placental villous macrophages (Hofbauer cells) and alpha-fetoprotein positive embryonic cells, indicating transplacental transmission (Figure S1A–K).
Table:
Clinical characteristics, virology and pregnancy outcomes in women infected with clade Ib MPXV
| Case 1 | Case 2 | Case 3 | |
|---|---|---|---|
| Clinical presentation | |||
| Age% (years) | 20-30 | 25-35 | 20-30 |
| Gestational age at diagnosis of infection (weeks) | 6 | 16 | 34 |
| HIV status | Unknown | Positive | Positive |
| Receiving ART | NA | Yes | No |
| Mode of transmission | Sexual contact | Sexual contact | Skin to skin contact |
| Symptoms | Fever, skin lesions generalized and genital, inguinal adenopathy, pruritus, genital pain, vaginal discharge, labial edema | Fever, skin lesions generalized and genital, inguinal adenopathy, genital pain | Fever, dysphagia, dehydration, hypotension, generalized skin lesions, ulcerative genital lesions, generalized pruritus |
| Number of lesions | 100-250 | > 250 | > 250 |
| WHO severity score* | Severe | Grave | Grave |
| Pregnancy outcome | Spontaneous abortion | IUFD | Live neonate with congenital mpox |
| MPXV-PCR results | |||
| Skin lesion mother | Pos (Ct 23.5) | NA | Pos (Ct 21.8) |
| Oro-pharyngeal swab mother | Pos (Ct 30.5) | Pos (Ct 38.6) | Pos (Ct 30.5) |
| Vaginal swab mother | NA | Pos (Ct 35.1) | NA |
| Blood mother | Pos (Ct 33.1) | Neg | NA |
| Breast milk | NA | Pos (Ct 39) | Neg |
| Placenta swab | Pos (Ct 20.1) | Pos (Ct 19.3) | Pos (Ct 23.7) |
| Swab of fetal or embryonic products or live newborn | Pos (Ct 13.4) | Pos (Ct 18.3) | Pos (Ct 38.2) |
| MPXV Clade identification | Ib | Ib | Ib |
Abbreviations: IUFD denotes intra-uterine fetal demise, Pos denotes MPXV DNA detected, Neg denotes MPXV not detected, Ct denotes Cycle Threshold Value, ART denotes antiretroviral therapy, NA denotes ‘not available’ or ‘not applicable’.
Age ranges are provided to avoid patient identification.
WHO severity score based on number of lesions: mild (< 25 lesions); moderate (25-99 lesions); severe (100-250 lesions), grave (> 250 lesions).
The second case involved an HIV-positive woman at 16 weeks of gestation who presented with widespread vesiculopustular lesions, fever, and dysphagia. Fifteen days after she tested positive for Clade Ib MPXV, fetal movements ceased, and ultrasound confirmed intrauterine fetal demise. A cesarean delivery was performed after unsuccessful labor induction; the fetus had several mpox-like lesions on the face, chest, abdomen, and upper limbs. MPXV DNA was detected in placental and fetal tissue, with Ct-values of 19.3 and 18.3, respectively (Table).
The third case involved an HIV-positive woman at 34 weeks of gestation with generalized mpox lesions, and genital ulcers, who tested positive for Clade Ib MPXV. She was admitted with hypotension but recovered and was discharged after 29 days. Thirteen days later, at 40 weeks gestation, she delivered a live infant with multiple ulcerative skin lesions (Figure S2); MPXV DNA was detected in placental swab (Ct 23.7) and oropharyngeal swab from the newborn (Ct 38.2). Histopathology revealed MPXV antigen within the placental villi, co-localized with CD68 positive-cells (Figure S1L–P). The mother reported the infant’s death three months later, likely unrelated to mpox.
These findings provide evidence that Clade Ib MPXV can be vertically transmitted, resulting in pregnancy loss or congenital infection, consistent with isolated previous reports on Clade Ia MPXV.1,2 These findings support the need for preventive interventions in pregnant women, including vaccination. Prospective large scale studies are required to better understand perinatal outcomes associated with mpox in pregnancy and to guide clinical management.
Supplementary Material
Acknowledgments
This work was funded by the Belgian Directorate-General for Development Cooperation and Humanitarian Aid (grant number 914010) and the European & Developing Countries Clinical Trials Partnership EDCTP3 (grant number 101195465 and 101195146). Complementary support was provided by the Research Foundation – Flanders (FWO, grant number G096222N to LL, JJM and 12B1M24N to CVD) and through the African coalition for Epidemic Research, Response and Training (ALERRT) network. ALERRT is part of the EDCTP2 Programme supported by the European Union under grant agreement RIA2016E-1612. Additionally, this research was supported by the Japan Agency for Medical Research and Development (AMED) with grant number JP24fk0108637 and JP24fk0108660. Work was partially funded with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. 75N91019D00024 and funding from the Canadian Institutes of Health Research and International Development Research Centre (grant no. MRR-184813).
Footnotes
Disclosure forms provided by the authors are available with the full text of this letter at NEJM.org.
The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.
References
- 1.Schwartz DA, Mbala-Kingebeni P, Patterson K, Huggins JW & Pittman PR Congenital Mpox Syndrome (Clade I) in Stillborn Fetus after Placental Infection and Intrauterine Transmission, Democratic Republic of the Congo, 2008. Emerg Infect Dis 29, (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Pittman PR et al. Clinical characterization and placental pathology of mpox infection in hospitalized patients in the Democratic Republic of the Congo. PLoS Negl Trop Dis 17, e0010384 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Nachega JB et al. Mpox in Pregnancy — Risks, Vertical Transmission, Prevention, and Treatment. New England Journal of Medicine (2024) doi: 10.1056/NEJMp2410045. [DOI] [PubMed] [Google Scholar]
- 4.Brosius I et al. Epidemiological and clinical features of mpox during the clade Ib outbreak in South Kivu, Democratic Republic of the Congo: a prospective cohort study. The Lancet (2025) doi: 10.1016/S0140-6736(25)00047-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
